Achieving Extended Release By Coating Oral Solid Dosage.
Student Name
American Public University
COURSE####: Course Title
Instructor Name
Due Date
Achieving Extended Release By Coating Oral Solid Dosage.
Introduction.
Different drug products are made to lower the frequency of dosage by changing the rate at with the respective drug is absorbed. As stated by the Australian government, the modified release oral dosages occur in formulations such as delayed-release and extended-release. Common modified extended-release systems include; matrix system, reservoir system, and osmotic system. For the past three decades, the oral modified release system has undergone technological and infrastructural development and improvement to provide effective and quality drugs for respective patients.
Extended-Release Systems.
Successful integration of chemical and physical properties and designs significantly impacts the process of designing various oral extended-release dosages that prolong the drug’s effect while in the gastrointestinal tract. Most of the oral extended-release formulations are made by embodying the proprietary and non-proprietary extended release technologies that are founded on polymeric innovations. Likely, most of the oral extended-release drugs fall either in three divisions; reservoir systems, matrix systems, and osmotic systems [i](Maderuelo, Lanao & Zarzuelo, 2019, np). Remarkably, all the drugs that are manufactured using the extended delivery systems entail various mechanisms such as system swelling, diffusion of the drug, dissolution, and erosion, release that is linked to osmotic pressure.
Matrix system.
In light of this system, the chemicals that are used to manufacture the drug, are well mixed with the materials that control rate to attain a homogenous mixture. The drugs that are manufactured using the matrix system, they release the medicinal components through erosion or diffusion from the system [ii](Qiu & Zhou, 2020). Following the varying rate and properties of the rate-controlling material, the matrix system can either be defined as hydrophilic or water-insoluble systems. In the hydrophilic systems, the materials that control the rate of absorption are soluble in water while on the other hand, there are water-insoluble materials that rarely dissolve.
Notably, the matrix system is highly applied for the extended-release of medicinal materials due owing to its versatility and increased effectiveness. Moreover, this system allows the administration of high and low concentrations of drugs with drugs that have a large range of physicochemical features. In comparison with the other forms of drug delivery systems, the matrix is effective in terms of costs of production and is easily scalable and has fewer manufacturing processes.
Hydrophilic Matric System
The hydrophilic matrix release system entails the application of two processes; relaxational release and fiction diffusional. In the hydrophilic matrix, the sole rate controlling substances are polymers that characteristically hydrate and swell faster when placed in water to form a gel-like coating on the outer surface of the system [iii](Debotton & Dahan, 2016, 52). Besides the diffusion of drugs across the viscous gel coating, erosion further facilitates the movement of the pharmacological material across the layers. The erosion occurs due to the dissolution of the relaxation of the polymers. Furthermore, changes in the diffusion system affect the diffusional release of the drug into the body of the respective patient.
Hydrophobic Matrix System.
The hydrophobic matrix system was the first technology to develop oral extended release drugs. For instance, the Premarin tablet that was first developed in 1942 [iv](Kanasty et al., 2019, 35). In this matrix, there is a dispersion of the drug in the matrix. In this regard, most of the diffusion-based matrix systems, the pathway for diffusion increases while the corresponding release surface decreases.
Reservoir System
Extended drug release can also be done through the reservoir system. This system is usually applied when controlling active agents that are soluble in water. Typically, a reservoir system entails a drug that has an insoluble film on the surrounding. In a bid to establish a porous membrane, a leachable additive or soluble substance is normally included in the drug. Such substance may be a plasticizer or a polymer that is soluble in water [v](Khatri, Desai, Shelke & Minko, 2018, 231). A preferred reservoir system usually consists of various coated substances like pellets, beads, and small tablets. Besides, the multi-unit system allows a tailored pharmacological substance to can be formulated by combining various units with different release features. Likewise, this system is easily adaptable to varying strength of doses with less need for formulation change.
Osmotic Pump System.
Osmotic pump systems are almost similar to the reservoir system. This pump embodies a drug that has a core housed in an insoluble membrane. However, the osmotic pump has an orifice for the release of the drug and its core entails osmotic agent functions as an imbibe water that comes from the medium around via the semi-permeable layer. Such a devise was first discussed by Higuchi and Theeuwes in 1975 [vi](Raza, Shen, Li, Chen & Wang, 2019, 163). The release of the drug from this device is managed by an influx of water across the semi-permeable layer. The size of the orifice is made to lower diffusion rate thus reducing the chances of the build-up of the hydrostatic pressure that transition to osmotic pressure, hence interfering with the volume of the device. Notably, in the development of the osmotic pump systems, the elementary osmotic pump has been utilized.
Conclusion.
Over the years, there has been a technological and infrastructural change that has influenced the manufacturing of oral drugs. For instance, the establishment of extended-release technologies has effectively impacted the frequency of drug consumption among patients as described above. Such technologies entails the modified extended-release systems like; matrix system, reservoir system, and osmotic system. Formulating drugs in this format results in reduced rate of drug consumption since the pharmacological components are able to stay in the body much longer.
[i] Maderuelo, C., Lanao, J., & Zarzuelo, A. (2019). Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability. European Journal of Pharmaceutical Sciences, 138, 105019. doi: 10.1016/j.ejps.2019.105019
[ii] Qiu, Y., & Zhou, D. (2020). Understanding Design and Development of Modified Release Solid Oral Dosage Forms. Journal Of Validation Technology, 1(1), 23-32.
[iii] Debotton, N., & Dahan, A. (2016). Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms. Medicinal Research Reviews, 37(1), 52-97. doi: 10.1002/med.21403
[iv] Kanasty, R., Low, S., Bhise, N., Yang, J., Peeke, E., & Schwarz, M. et al. (2019). A pharmaceutical answer to nonadherence: Once weekly oral memantine for Alzheimer’s disease. Journal of Controlled Release, 303, 34-41. doi: 10.1016/j.jconrel.2019.03.022
[v] Khatri, P., Desai, D., Shelke, N., & Minko, T. (2018). Role of plasticizer in membrane coated extended release oral drug delivery system. Journal of Drug Delivery Science and Technology, 44, 231-243. doi: 10.1016/j.jddst.2017.12.020 (Khatri, Desai, Shelke & Minko, 2018)
[vi] Raza, A., Shen, N., Li, J., Chen, Y., & Wang, J. (2019). Formulation of zein based compression coated floating tablets for enhanced gastric retention and tunable drug release. European Journal of Pharmaceutical Sciences, 132, 163-173. doi: 10.1016/j.ejps.2019.01.025
Smicer's Blog 